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Correlation
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Michael C DiMarino, MD; Anthony DiMarino, MD

(*) indicates primary project advisor

Introduction & Objectives
•

Celiac Disease (CD) has a prevalence of 1-2% across the globe.1
– Intestinal lymphocytosis, villous atrophy, and crypt hyperplasia of intestinal
lumen 2
– Graded on a scale of 0-3c (Marsh scores)

•

Major problem = diagnosis
– A study done in Italy reported approximately seven out of eight celiac patients
go undiagnosed due to minor but significant symptoms.3
– A failure to diagnose CD in patients can result in complications such as severe
osteoporosis and intestinal lymphoma.4

•

Correlation studies between symptoms, serology (tTG-IgA antibodies) and
histological severity (Marsh scores) could assist physicians at large
university referral centers, such as Thomas Jefferson University Hospital, in
diagnosing CD.

Intestinal Lymphocytosis, Villus Atrophy and Crypt Hyperplasia

Research Question
•

Research Question: Is there a correlation between
symptoms/complications, tTG IgA antibodies, presenting age and Marsh
scores for patients presenting with Celiac Disease at Thomas Jefferson
University Hospital?
– Purpose: To establish useful relationships for physicians by creating correlation
studies between Marsh scores, associated symptoms, BMI, presenting age and
tTG IgA antibodies as well as establishing the common presenting symptoms
for celiac patients.
– Variables: Marsh scores, symptoms/complications, tTG-IgA antibodies, BMI,
presenting age
– Population: 140 patients that presented with Celiac disease at Jefferson
hospitals as location has been shown to be a factor affecting the genetics
behind the disease.6

Specific Aims and Hypothesis
1.
2.

Find the most common presenting symptoms of patients with Celiac
disease
Create a correlation study between Marsh scores (pathologic severity)
and tTG-IgA antibodies (serologic severity)
•

3.

Identify the relationship between Marsh scores and presenting age.
•

4.

Proposed hypothesis: As the pathologic severity increases in celiac patients, so will the
serologic severity resulting in a significant positive correlation.
Proposed hypothesis: As presenting age increases so will the pathologic severity of the
disease.

Determine the average body mass index (BMI).
•

5.

Proposed hypothesis: The average BMI for patients presenting with Celiac will be lownormal due to patients’ malabsorption.

Identify the gender breakdown of patients presenting with celiac
disease.
•

Proposed hypothesis: Like other autoimmune diseases, more women will present with
celiac disease compared to men.

Methods
•
•

•
•
•

•
•

Study design: Retrospective chart review at an urban, tertiary hospital
(Thomas Jefferson University Hospital)
Population / study sample: patients diagnosed with Celiac Disease at
Thomas Jefferson University Hospital (TJUH) with both a Marsh score and
a tTG-IgA antibody result.
Intervention: none (retrospective study)
Comparison group: not applicable
Outcome (dependent variables): Age at diagnosis, BMI, presenting
symptoms/complications, appropriate clinical values (Marsh score and
tTG-IgA antibody result), adherence to diet
Data source and collection: Access to EPIC was granted through an OHR12B submission.
Analysis via correlation statistics using Marsh scores and tTG-IgA antibody
values
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Presenting Symptoms

Some patients have more than one symptom thus making the total >100%. Patients
reported with no symptoms were evaluated because of family history. The three major
presenting symptoms were abdominal pain, bloating, and diarrhea. These symptoms
were gathered in a record review of chief presenting symptoms to a gastroenterology
practice.
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50.0%
45.0%
40.0%

% of Patients

35.0%
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%

0-30

31-40

41-50
0

1

Age
2 3A

51-60
3B

60+

3C

Diagnostic criteria for celiac disease was defined as a positive biopsy (>0) and/or
positive serology (elevated TTG IgA/IgG antibodies). Patients who presented with
a Marsh score of zero had positive serology. There was a wide variation in Marsh
scores with no particular pattern identified when evaluated by age.
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As per CDC guidelines, a healthy BMI is between 18.5 and 24.9 kg/m2 as outlined by the dashed
lines. Out of the 84 patients that had their BMI calculated, 40 patients (48%) had a BMI at
presentation that was between these values, 5 patients (6%) were below, and 39 patients (46%)
were above the recommended BMI of 24.9 kg/m2. Of the 39 patients with a BMI over 24.9 kg/m2, 19
patients (23%) were considered obese at a BMI over 30 kg/m2.
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Conclusions
1. There were a wide variety of presenting symptoms for
celiac patients. The three major presenting symptoms
were abdominal pain, bloating, and diarrhea.
2. We did not find a correlation between Marsh scores and
tTG-IgA antibodies.
3. We did not find a correlation between presenting age
and Marsh score.
4. 46% of patients presented with a BMI of over 24.9
kg/m2.
5. 73% of presented celiac patients identified as female.

Future Direction
• The wide variety of presenting symptoms for
Celiac Disease along with the lack of positive
correlation between serology and pathology
warrant further evaluation for the efficacy of
implementing a Celiac screening protocol.
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